175 related articles for article (PubMed ID: 8671652)
1. Identification of A2-restricted hepatitis C virus-specific cytotoxic T lymphocyte epitopes from conserved regions of the viral genome.
Wentworth PA; Sette A; Celis E; Sidney J; Southwood S; Crimi C; Stitely S; Keogh E; Wong NC; Livingston B; Alazard D; Vitiello A; Grey HM; Chisari FV; Chesnut RW; Fikes J
Int Immunol; 1996 May; 8(5):651-9. PubMed ID: 8671652
[TBL] [Abstract][Full Text] [Related]
2. CTL responses of HLA-A2.1-transgenic mice specific for hepatitis C viral peptides predict epitopes for CTL of humans carrying HLA-A2.1.
Shirai M; Arichi T; Nishioka M; Nomura T; Ikeda K; Kawanishi K; Engelhard VH; Feinstone SM; Berzofsky JA
J Immunol; 1995 Mar; 154(6):2733-42. PubMed ID: 7533182
[TBL] [Abstract][Full Text] [Related]
3. Development of a DNA vaccine designed to induce cytotoxic T lymphocyte responses to multiple conserved epitopes in HIV-1.
Wilson CC; McKinney D; Anders M; MaWhinney S; Forster J; Crimi C; Southwood S; Sette A; Chesnut R; Newman MJ; Livingston BD
J Immunol; 2003 Nov; 171(10):5611-23. PubMed ID: 14607970
[TBL] [Abstract][Full Text] [Related]
4. Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules.
Battegay M; Fikes J; Di Bisceglie AM; Wentworth PA; Sette A; Celis E; Ching WM; Grakoui A; Rice CM; Kurokohchi K
J Virol; 1995 Apr; 69(4):2462-70. PubMed ID: 7884894
[TBL] [Abstract][Full Text] [Related]
5. Pools of lipidated HTL-CTL constructs prime for multiple HBV and HCV CTL epitope responses.
Oseroff C; Sette A; Wentworth P; Celis E; Maewal A; Dahlberg C; Fikes J; Kubo RT; Chesnut RW; Grey HM; Alexander J
Vaccine; 1998 May; 16(8):823-33. PubMed ID: 9627940
[TBL] [Abstract][Full Text] [Related]
6. Optimization and immune recognition of multiple novel conserved HLA-A2, human immunodeficiency virus type 1-specific CTL epitopes.
Corbet S; Nielsen HV; Vinner L; Lauemoller S; Therrien D; Tang S; Kronborg G; Mathiesen L; Chaplin P; Brunak S; Buus S; Fomsgaard A
J Gen Virol; 2003 Sep; 84(Pt 9):2409-2421. PubMed ID: 12917462
[TBL] [Abstract][Full Text] [Related]
7. Use of recombinant protein to identify a motif-negative human cytotoxic T-cell epitope presented by HLA-A2 in the hepatitis C virus NS3 region.
Kurokohchi K; Akatsuka T; Pendleton CD; Takamizawa A; Nishioka M; Battegay M; Feinstone SM; Berzofsky JA
J Virol; 1996 Jan; 70(1):232-40. PubMed ID: 8523531
[TBL] [Abstract][Full Text] [Related]
8. Characterization of an immunologically conserved epitope from hepatitis C virus E2 glycoprotein recognized by HLA-A2 restricted cytotoxic T lymphocytes.
Sarobe P; Huarte E; Lasarte JJ; López-Díaz de Cerio A; García N; Borrás-Cuesta F; Prieto J
J Hepatol; 2001 Feb; 34(2):321-9. PubMed ID: 11281563
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif.
Cerny A; McHutchison JG; Pasquinelli C; Brown ME; Brothers MA; Grabscheid B; Fowler P; Houghton M; Chisari FV
J Clin Invest; 1995 Feb; 95(2):521-30. PubMed ID: 7860734
[TBL] [Abstract][Full Text] [Related]
10. Identification of HLA-A3 and -B7-restricted CTL response to hepatitis C virus in patients with acute and chronic hepatitis C.
Chang KM; Gruener NH; Southwood S; Sidney J; Pape GR; Chisari FV; Sette A
J Immunol; 1999 Jan; 162(2):1156-64. PubMed ID: 9916747
[TBL] [Abstract][Full Text] [Related]
11. Identification of new melanoma epitopes on melanosomal proteins recognized by tumor infiltrating T lymphocytes restricted by HLA-A1, -A2, and -A3 alleles.
Kawakami Y; Robbins PF; Wang X; Tupesis JP; Parkhurst MR; Kang X; Sakaguchi K; Appella E; Rosenberg SA
J Immunol; 1998 Dec; 161(12):6985-92. PubMed ID: 9862734
[TBL] [Abstract][Full Text] [Related]
12. Immunogenic variation between multiple HLA-A*0201-restricted, Hepatitis C Virus-derived epitopes for cytotoxic T lymphocytes.
Ohno S; Moriya O; Yoshimoto T; Hayashi H; Akatsuka T; Matsui M
Viral Immunol; 2006; 19(3):458-67. PubMed ID: 16987064
[TBL] [Abstract][Full Text] [Related]
13. HLA A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection.
Nayersina R; Fowler P; Guilhot S; Missale G; Cerny A; Schlicht HJ; Vitiello A; Chesnut R; Person JL; Redeker AG; Chisari FV
J Immunol; 1993 May; 150(10):4659-71. PubMed ID: 7683326
[TBL] [Abstract][Full Text] [Related]
14. Human memory CTL response specific for influenza A virus is broad and multispecific.
Gianfrani C; Oseroff C; Sidney J; Chesnut RW; Sette A
Hum Immunol; 2000 May; 61(5):438-52. PubMed ID: 10773346
[TBL] [Abstract][Full Text] [Related]
15. Differences and similarities in the A2.1-restricted cytotoxic T cell repertoire in humans and human leukocyte antigen-transgenic mice.
Wentworth PA; Vitiello A; Sidney J; Keogh E; Chesnut RW; Grey H; Sette A
Eur J Immunol; 1996 Jan; 26(1):97-101. PubMed ID: 8566090
[TBL] [Abstract][Full Text] [Related]
16. Enhanced in vitro potency and in vivo immunogenicity of a CTL epitope from hepatitis C virus core protein following amino acid replacement at secondary HLA-A2.1 binding positions.
Sarobe P; Pendleton CD; Akatsuka T; Lau D; Engelhard VH; Feinstone SM; Berzofsky JA
J Clin Invest; 1998 Sep; 102(6):1239-48. PubMed ID: 9739058
[TBL] [Abstract][Full Text] [Related]
17. HLA-A2-restricted cytotoxic T lymphocyte responses to multiple Plasmodium falciparum sporozoite surface protein 2 epitopes in sporozoite-immunized volunteers.
Wizel B; Houghten R; Church P; Tine JA; Lanar DE; Gordon DM; Ballou WR; Sette A; Hoffman SL
J Immunol; 1995 Jul; 155(2):766-75. PubMed ID: 7541824
[TBL] [Abstract][Full Text] [Related]
18. Genetic immunization and comprehensive screening approaches in HLA-A2 transgenic mice lead to the identification of three novel epitopes in hepatitis C virus NS3 antigen.
Martin P; Parroche P; Chatel L; Barretto C; Beck A; Trépo C; Bain C; Lone YC; Inchauspé G; Fournillier A
J Med Virol; 2004 Nov; 74(3):397-405. PubMed ID: 15368525
[TBL] [Abstract][Full Text] [Related]
19. An epitope in hepatitis C virus core region recognized by cytotoxic T cells in mice and humans.
Shirai M; Okada H; Nishioka M; Akatsuka T; Wychowski C; Houghten R; Pendleton CD; Feinstone SM; Berzofsky JA
J Virol; 1994 May; 68(5):3334-42. PubMed ID: 7512163
[TBL] [Abstract][Full Text] [Related]
20. Identification of cytotoxic T lymphocyte epitopes in dengue virus serotype 1.
Duan Z; Guo J; Huang X; Liu H; Chen X; Jiang M; Wen J
J Med Virol; 2015 Jul; 87(7):1077-89. PubMed ID: 25777343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
